Welcome to Coulter Partners Global (English)

13 May 2026

Coulter Partners at BioEquity Europe 2026: Driving the global talent narrative in Prague

The European biotech ecosystem recently converged in Prague for the 26th edition of BioEquity Europe. Anchored by the timely theme, "Need for Speed: How Europe Can Compete in the New Era," the conference brought together leading biopharma decision-makers and specialized investors to forge new partnerships and tackle the industry's most pressing leadership challenges.

Representing Coulter Partners on the ground was a senior team including Executive Chair Bianca Coulter, alongside Partners Francesca Lazzarin, Laura Esam, and Nanna Soni.

Leading the conversation: "Winning the Talent Race"

A major highlight of the event took place on May 5th, when Bianca Coulter joined a panel of industry experts to discuss: ‘Winning the talent race: Best practices on hiring, nurturing, and retaining top talent in a global environment.’ Moderated by Carole Nuechterlein (Former Head of the Roche Venture Fund), the panel featured prominent sector voices:

  • Allan Marchington (Intermediate Capital Group - ICG)
  • Luc Dochez (Droia Ventures)
  • Maina Bhaman (Sofinnova Partners)
  • Radek Spisek (SOTIO Biotech)

The highly engaging session dove into the critical intersection of R&D excellence and global commercial execution. Key debates centered on how the speed of leadership decision-making serves to de-risk assets for investors, and the strategies required to attract experienced operators to Europe via a borderless talent approach.

Key Takeaways:

The panel sparked excellent follow-up dialogues with CEOs and investors regarding the relative merits and operational hurdles of different business models – specifically, the pros and cons of co-location versus virtual or remote working.

In a rapidly shifting market, a primary hurdle for leadership is managing the attraction, retention, and development of top-tier talent when the precise expertise required isn't located nearby. Finding the right balance remains a critical evolutionary step for modern biotech CEOs.


Boots on the ground: market and leadership intelligence

Beyond the talent debate, the Coulter Partners team gathered vital market intelligence from delegates regarding the current funding environment and organizational design.

  • The funding landscape: Feedback from attendees highlighted a bifurcated market. While it remains noticeably tough for certain pre-Proof of Concept (pre-POC) data models to raise capital without highly disruptive innovation, optimism is returning. Several companies are expecting to close significant rounds imminently, and investors expressed notable excitement about the increasing volume of "stronger" companies currently stabilizing their portfolios.
  • Evolving leadership themes: Conversations with leadership teams focused heavily on operational excellence. Key priorities for firms right now include optimizing C-suite structures, mastering the precise timing of critical hires, addressing demand for specialized skill sets, managing robust succession planning, and evolving Board compositions to effectively meet current market demands.


Connect with our team

If you did not get a chance to connect with our team on-site but are looking to scale your executive team, build an effective Board, or discuss leadership strategies that drive sustainable growth, our partners would love to hear from you.

Get in touch with Bianca Coulter, Francesca Lazzarin, Laura Esam, or Nanna Soni to arrange a conversation.

Related

A new version of Coulter Partners is available.